Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital.
Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):146-151. doi: 10.1097/MCO.0000000000000548.
The intended purpose of nutritional and exercise interventions during ICU stay is often to limit the muscle loss associated with critical illness. Unfortunately, direct measurements of muscle protein turnover or potential surrogates have often been neglected in clinical trials.
We discuss the potential advantages and drawbacks of common outcome measures for assessing changes in muscle structure and function over time, and how temporal changes in patient physiology require consideration. There is an increasing awareness of emphasizing functional outcomes in recent clinical trials. We here summarize the latest research on therapies attempting to limit muscle loss in ICU patients, with a focus on muscle protein metabolism. No recent or older studies show any effect of nutritional interventions on muscle protein gain, although some smaller studies show a promising positive effect on muscle thickness and function. Some studies show a positive effect of increased physical activity in the ICU on muscle mass and function but heterogeneity of the interventions and outcome measures make any general conclusions impossible.
Several knowledge gaps remain regarding the importance of muscle protein regulation as a driver of improved physical function following ICU discharge. In our opinion, physiological investigations are needed to guide the design and interpretation of future clinical trials.
在 ICU 住院期间进行营养和运动干预的目的通常是限制与危重病相关的肌肉损失。不幸的是,临床试验往往忽略了对肌肉蛋白质周转率的直接测量或潜在的替代指标。
我们讨论了评估肌肉结构和功能随时间变化的常用结果测量的潜在优缺点,以及患者生理学的时间变化需要考虑。最近的临床试验越来越重视强调功能结果。我们在这里总结了最近关于试图限制 ICU 患者肌肉损失的治疗方法的最新研究,重点是肌肉蛋白质代谢。最近或以前的研究都没有显示营养干预对肌肉蛋白质增加有任何影响,尽管一些较小的研究显示出对肌肉厚度和功能有有希望的积极影响。一些研究表明 ICU 中增加身体活动对肌肉质量和功能有积极影响,但干预措施和结果测量的异质性使得不可能得出任何一般性结论。
关于肌肉蛋白质调节作为改善 ICU 出院后身体功能的驱动因素的重要性,仍存在一些知识空白。我们认为,需要进行生理研究来指导未来临床试验的设计和解释。